RNF175
RING finger protein 175
Also known as: FLJ34190, RN175_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8N4F7
- Gene
- RNF175
- Ensembl
- ENSG00000145428
- Chromosome
- 4
- Canonical length
- 328 aa
- Protein class
- Predicted membrane proteins
OverviewNCBI Gene
Predicted to enable ubiquitin protein ligase activity. Predicted to be involved in ERAD pathway. Predicted to be located in membrane. Predicted to be active in Golgi membrane and endoplasmic reticulum membrane. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
328 residues, UniProt reviewed canonical sequence.
>Q8N4F7|RNF175
1 MAAGTAARKA APVLEAPPQQ EQLSHTKLSA EDTWNLQQER MYKMHRGHDS MHVEMILIFL
61 CVLVIAQIVL VQWRQRHGRS YNLVTLLQMW VVPLYFTIKL YWWRFLSMWG MFSVITSYIL
121 FRATRKPLSG RTPRLVYKWF LLIYKLSYAF GVVGYLAIMF TMCGFNLFFK IKARDSMDFG
181 IVSLFYGLYY GVMGRDFAEI CSDYMASTIG FYSVSRLPTR SLSDNICAVC GQKIIVELDE
241 EGLIENTYQL SCNHVFHEFC IRGWCIVGKK QTCPYCKEKV DLKRMISNPW ERTHFLYGQI
301 LDWLRYLVAW QPVVIGIVQG IIYSLGLELocalizationUniProt · AlphaFold · HPA
Whether an antibody against RNF175 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 4
- Mean surface accessibility (rSASA)
- 0.36
- Highest tissue expression
- 26 nTPM
Expression across tissuesHPA
Tissue
- cerebral cortex: 26 nTPM
- basal ganglia: 21 nTPM
- hypothalamus: 18 nTPM
- cerebellum: 15 nTPM
- hippocampal formation: 13 nTPM
- amygdala: 13 nTPM
Single-cell type
- pituitary stem cells: 367 nCPM
- brain inhibitory neurons: 112 nCPM
- other brain neurons: 97 nCPM
- neutrophils: 87 nCPM
- brain excitatory neurons: 86 nCPM
- late primary spermatocytes: 65 nCPM
Immune cell
- neutrophil: 2.4 nTPM
- naive CD4 T-cell: 2.2 nTPM
- non-classical monocyte: 2.1 nTPM
- classical monocyte: 1.2 nTPM
- intermediate monocyte: 0.9 nTPM
- myeloid DC: 0.9 nTPM
Brain region
- hypothalamus: 27 nTPM
- cerebral cortex: 26 nTPM
- basal ganglia: 20 nTPM
- thalamus: 19 nTPM
- pons: 18 nTPM
- white matter: 17 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.43
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.16
- DepMap mean gene effect
- 0.06
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads RNF175 as an antibody target. Whether an autoantibody or antibody against RNF175 could matter depends on whether native RNF175 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
RNF175 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label RNF175 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...